Chiloiro, Giuditta
 Distribuzione geografica
Continente #
NA - Nord America 2.206
AS - Asia 1.787
EU - Europa 1.630
SA - Sud America 491
AF - Africa 73
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.197
Nazione #
US - Stati Uniti d'America 2.112
SG - Singapore 851
DE - Germania 425
BR - Brasile 404
SE - Svezia 389
CN - Cina 388
IT - Italia 222
IN - India 156
FR - Francia 136
VN - Vietnam 109
IE - Irlanda 94
FI - Finlandia 91
GB - Regno Unito 71
ID - Indonesia 66
HK - Hong Kong 39
CA - Canada 36
MX - Messico 36
AR - Argentina 35
RU - Federazione Russa 34
UA - Ucraina 32
AT - Austria 29
CI - Costa d'Avorio 27
IQ - Iraq 27
BD - Bangladesh 26
PL - Polonia 24
TR - Turchia 23
KR - Corea 22
CZ - Repubblica Ceca 17
ZA - Sudafrica 17
BE - Belgio 16
NL - Olanda 15
JP - Giappone 13
CO - Colombia 11
VE - Venezuela 10
CL - Cile 8
EC - Ecuador 8
ES - Italia 8
MA - Marocco 8
SA - Arabia Saudita 8
PE - Perù 7
PK - Pakistan 7
IL - Israele 6
IR - Iran 6
TT - Trinidad e Tobago 6
AU - Australia 5
CH - Svizzera 5
PH - Filippine 5
TN - Tunisia 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
HN - Honduras 4
KE - Kenya 4
PA - Panama 4
UZ - Uzbekistan 4
CR - Costa Rica 3
DZ - Algeria 3
ET - Etiopia 3
GE - Georgia 3
LT - Lituania 3
NZ - Nuova Zelanda 3
PY - Paraguay 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
EG - Egitto 2
EU - Europa 2
JM - Giamaica 2
JO - Giordania 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LV - Lettonia 2
MN - Mongolia 2
NP - Nepal 2
OM - Oman 2
PS - Palestinian Territory 2
SC - Seychelles 2
AM - Armenia 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
DK - Danimarca 1
GM - Gambi 1
HU - Ungheria 1
KH - Cambogia 1
LU - Lussemburgo 1
MM - Myanmar 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
PT - Portogallo 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
Totale 6.197
Città #
Singapore 429
Chandler 402
Ashburn 259
Frankfurt am Main 136
New York 130
Beijing 97
Dublin 94
Munich 93
Los Angeles 80
Hyderabad 74
The Dalles 65
Hefei 61
Rome 58
Jakarta 55
Milan 54
São Paulo 51
Ann Arbor 48
Ho Chi Minh City 45
Helsinki 41
Hong Kong 38
Princeton 36
Bremen 32
San Mateo 31
Marseille 29
Turku 28
Abidjan 27
Jacksonville 27
Chicago 26
Boston 25
Wilmington 25
Dallas 22
Seoul 22
Hanoi 21
Moscow 21
London 20
Santa Clara 20
Vienna 20
Brooklyn 18
Kent 18
Buffalo 17
Houston 17
Nuremberg 17
Phoenix 16
Stockholm 16
Denver 15
Lappeenranta 15
North Bergen 15
Brno 14
Brussels 14
Nanjing 14
Orem 14
Poplar 14
Warsaw 14
Columbus 13
Dearborn 13
Rio de Janeiro 13
Tokyo 13
Fairfield 12
Toronto 12
Atlanta 11
Düsseldorf 11
Mexico City 11
Montreal 11
Johannesburg 10
Nürnberg 10
Redwood City 10
Izmir 9
Seattle 9
Woodbridge 9
Baghdad 8
Boardman 8
Campinas 8
San Francisco 8
San Jose 8
Ankara 7
Belo Horizonte 7
Falkenstein 7
Fortaleza 7
Haiphong 7
Miami 7
Mumbai 7
Nanchang 7
Porto Alegre 7
Washington 7
Augusta 6
Da Nang 6
Lawrence 6
Newark 6
Secaucus 6
Tampa 6
Turin 6
Biên Hòa 5
Brasília 5
Cattolica 5
Council Bluffs 5
Goiânia 5
Hangzhou 5
Itajaí 5
Kraków 5
Lima 5
Totale 3.364
Nome #
Does restaging MRI radiomics analysis improve pathological complete response prediction in rectal cancer patients? A prognostic model development 244
Automatic delineation for replanning in nasopharynx radiotherapy: what is the agreement among experts to be considered as benchmark? 206
International consensus guidelines on Clinical Target Volume delineation in rectal cancer 162
THUNDER 2: THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI guided radiotherapy 147
Fractal-based radiomic approach to predict complete pathological response after chemo-radiotherapy in rectal cancer 142
Advanced bladder cancer: New agents and new approaches. A review 141
Advanced bladder cancer: New agents and new approaches. A review 136
Delta radiomics for rectal cancer response prediction with hybrid 0.35 T magnetic resonance-guided radiotherapy (MRgRT): a hypothesis-generating study for an innovative personalized medicine approach 129
Delta Radiomics Analysis for Local Control Prediction in Pancreatic Cancer Patients Treated Using Magnetic Resonance Guided Radiotherapy 128
A field strength independent MR radiomics model to predict pathological complete response in locally advanced rectal cancer 122
THeragnostic utilities for neoplastic DisEases of the rectum by MRI guided radiotherapy (THUNDER 2) phase II trial: interim safety analysis 120
Automatic segmentation software in locally advanced rectal cancer: READY (REsearch program in Auto Delineation sYstem)-RECTAL 02: prospective study 116
BRIDGE -1 TRIAL: BReak Interval Delayed surgery for Gastrointestinal Extraperitoneal rectal cancer, a multicentric phase III randomized trial 113
Magnetic resonance–guided radiotherapy feasibility in elderly cancer patients: proposal of the MASTER scoring system 113
Low Tesla magnetic resonance guided radiotherapy for locally advanced cervical cancer: first clinical experience 109
A deep learning approach to generate synthetic CT in low field MR-guided radiotherapy for lung cases 108
The Role of Simultaneous Integrated Boost in Locally Advanced Rectal Cancer Patients with Positive Lateral Pelvic Lymph Nodes 108
Evaluation of a simplified optimizer for MR-guided adaptive RT in case of pancreatic cancer 103
Magnetic Resonance, Vendor-independent, Intensity Histogram Analysis Predicting Pathologic Complete Response After Radiochemotherapy of Rectal Cancer 102
Possible contribution of IMRT in postoperative radiochemotherapy for rectal cancer: Analysis on 1798 patients by prediction model 100
Use of Indirect Target Gating in Magnetic Resonance-guided Liver Stereotactic Body Radiotherapy: Case Report of an Oligometastatic Patient 97
Mesorectal motion evaluation in rectal cancer MR-guided radiotherapy: an exploratory study to quantify treatment margins 96
Predicting tumour motion during the whole radiotherapy treatment: a systematic approach for thoracic and abdominal lesions based on real time MR 96
Preoperative intensity-modulated radiotherapy with a simultaneous integrated boost combined with Capecitabine in locally advanced rectal cancer: Short-term results of a multicentric study 95
MR-guided radiotherapy in rectal cancer: First clinical experience of an innovative technology 95
Assessing Quality of Life with the Novel QLQ-CAX24 Questionnaire and Body Composition Parameters in Rectal Cancer Patients: A Single-Center Prospective Study 94
Fertility preservation in chemo-radiotherapy for rectal cancer: A combined approach 94
Timing to achieve the highest rate of pCR after preoperative radiochemotherapy in rectal cancer: a pooled analysis of 3085 patients from 7 randomized trials 94
Could the conservative approach be considered safe in the treatment of locally advanced rectal cancer in case of a clinical near-complete or complete response? A retrospective analysis 93
Current practices and perspectives on the integration of contrast agents in MRI-guided radiation therapy clinical practice: A worldwide survey 92
The 2017 Assisi Think Tank Meeting on rectal cancer: A positioning paper. 92
MRI-guided stereotactic radiation therapy for hepatocellular carcinoma: a feasible and safe innovative treatment approach 92
A deep learning approach to generate synthetic CT in low field MR-guided adaptive radiotherapy for abdominal and pelvic cases 92
Beyond geometrical overlap: a Dosimetrical Evaluation of automated volumes Adaptation (DEA) in head and neck replanning 91
Delta Radiomics Can Predict Distant Metastasis in Locally Advanced Rectal Cancer: The Challenge to Personalize the Cure 90
Fractal-Based Radiomic Approach to Tailor the Chemotherapy Treatment in Rectal Cancer: A Generating Hypothesis Study 89
A Predictive Model of 2yDFS During MR-Guided RT Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients 88
Delta radiomics for rectal cancer response prediction using low field magnetic resonance guided radiotherapy: an external validation 88
Patients’ satisfaction by smileintm totems in radiotherapy: A two-year mono-institutional experience 88
REPeated mAgnetic resonance Image-guided stereotactic body Radiotherapy (MRIg-reSBRT) for oligometastatic patients: REPAIR, a mono-institutional retrospective study 84
The 2017 Assisi Think Tank Meeting on rectal cancer: A positioning paper 80
Predictive and prognostic value of inflammatory markers in locally advanced rectal cancer (PILLAR) - A multicentric analysis by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Gastrointestinal Study Group 79
Magnetic resonance guided SBRT reirradiation in locally recurrent prostate cancer: a multicentric retrospective analysis 78
On-line adaptive MR guided radiotherapy for locally advanced pancreatic cancer: Clinical and dosimetric considerations 78
External Validation of Early Regression Index (ERITCP) as Predictor of Pathologic Complete Response in Rectal Cancer Using Magnetic Resonance-Guided Radiation Therapy 77
Reliability of ITV approach to varying treatment fraction time: A retrospective analysis based on 2D cine MR images 77
MOREOVER: multiomics MR-guided radiotherapy optimization in locally advanced rectal cancer 77
Hybrid MRI guided radiotherapy in locally advanced cervical cancer: Case report of an innovative personalized therapeutic approach 76
Radiotherapy & total neoadjuvant therapy for recurrent rectal cancer in previously irradiated patients, (RETRY): a multicenter prospective observational study 75
Multidisciplinary Management of Rectal Cancer: Questions and Answers 74
Case Report: First in Human Online Adaptive MR Guided SBRT of Peritoneal Carcinomatosis Nodules: A New Therapeutic Approach for the Oligo-Metastatic Patient 73
Four steps in the evolution of rectal cancer managements through 40 years of clinical practice: Pioneering, standardization, challenges and personalization 72
pCR and 2-Year Disease-Free Survival: A Combination of the Two Endpoints as a New Classification for Locally Advanced Rectal Cancer Patients-An Updated Pooled Analysis of Eleven International Randomized Trials 71
Phase I and II trial on infusional 5-fluorouracil and gefitinib in combination with preoperative radiotherapy in rectal cancer: 10-years median follow-up 70
Delta Radiomic Analysis of Mesorectum to Predict Treatment Response and Prognosis in Locally Advanced Rectal Cancer 66
Modern Techniques in Re-Irradiation for Locally Recurrent Rectal Cancer: A Systematic Review 66
Time to surgery and pathologic complete response after neoadjuvant chemoradiation in rectal cancer: A population study on 2094 patients 66
Magnetic resonance-guided stereotactic body radiation therapy (MRgSBRT) for oligometastatic patients: a single-center experience 65
Quantitative analysis of MRI-guided radiotherapy treatment process time for tumor real-time gating efficiency 65
Radiomics-enhanced early regression index for predicting treatment response in rectal cancer: a multi-institutional 0.35 T MRI-guided radiotherapy study 64
A deep learning approach to generate synthetic CT in low field MR-guided adaptive radiotherapy for abdominal and pelvic cases 62
Auto-segmentation of pelvic organs at risk on 0.35T MRI using 2D and 3D Generative Adversarial Network models 61
Rectal Sparing Approach after preoperative Radio- and/or Chemo-therapy (ReSARCh): a prospective, multicenter, observational study 58
Oncological outcomes of patients not undergoing Total Mesorectal Excision after local excision: rethinking surgical indications 51
Treatment volume, dose prescription and delivery techniques for dose-intensification in Rectal Cancer: A national survey 48
Time to surgery and pathologic complete response after neoadjuvant chemoradiation in rectal cancer: A population study on 2094 patients 47
Rectal sparing approach after preoperative radio - and/or Chemo-therapy (ReSARCh): a prospective, multicentre, observational study 11
Stereotactic radiotherapy for liver oligometastases: a pooled analysis following the estro/eortc consensus recommendations 4
Gender role in radiotherapy: psychosocial differences between males and females during cancer care: Single-centre report on adult and paediatric oncological patients 4
Patients’ perspective in anal cancer 3
Totale 6.287
Categoria #
all - tutte 28.246
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.246


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202183 0 0 0 0 0 6 11 5 14 16 29 2
2021/2022369 39 8 0 34 11 3 6 41 26 34 96 71
2022/20231.081 143 142 84 182 60 121 75 77 102 41 46 8
2023/2024599 27 139 25 50 31 131 31 16 10 21 51 67
2024/20251.455 22 28 89 60 120 65 49 54 186 163 355 264
2025/20262.261 488 144 279 523 578 249 0 0 0 0 0 0
Totale 6.287